Clinical Trials List
Protocol NumberMOST 109-2628-B-182A-007-, MOST 110-2628-B-182A-004-, MOST 111-2628-B-182A-001-
Not yet recruiting
2021-03-01 - 2023-07-31
Phase II
Recruiting1
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Tzu-Chen Yen Division of Nuclear Medicine
- 楊嵐燕 未分科
- Feng-Yuan Liu Division of Nuclear Medicine
- 楊嵐燕助理研究員
- Chun-Chieh Wang Division of Radiation Therapy
- Chyong-Huey Lai Division of Obstetrics & Gynecology
- 謝憬儀助理研究員 Division of Radiology
- 林育駿放射師 Division of Radiology
- 謝憬儀 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
30 participants
